K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5

Nature Immunology

Volumn 15, Issue 3, 2014, Pages 231-238

  Harikumar, Kuzhuvelil B ^a   Yester, Jessie W ^a   Surace, Michael J ^a   Oyeniran, Clement ^a   Price, Megan M ^a   Huang, Wei Ching ^a   Hait, Nitai C ^a   Allegood, Jeremy C ^a   Yamada, Akimitsu ^a,b   Kong, Xiangqian ^c   Lazear, Helen M ^d   Bhardwaj, Reetika ^a   Takabe, Kazuaki ^a,b   Diamond, Michael S ^d   Luo, Cheng ^c   Milstien, Sheldon ^a   Spiegel, Sarah ^a   Kordula, Tomasz ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOTAXIS, LEUKOCYTE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LYSINE; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84894477392     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2810     Document Type: Article

References (50)

1. Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550 (2009).
2. O'Neill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226, 10-18 (2008).
3. Arend, W.P. The balance between IL-1 and IL-1Rα in disease. Cytokine Growth Factor Rev. 13, 323-340 (2002).
4. Janssens, S. & Beyaert, R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27, 474-482 (2002).
5. Kim, T.W. et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204, 1025-1036 (2007).
6. Inoue, J., Gohda, J. & Akiyama, T. Characteristics and biological functions of TRAF Adv. Exp. Med. Biol. 597, 72-79 (2007).
7. Emmerich, C.H. et al. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. USA 110, 15247-15252 (2013).
8. Chen, Z.J. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765 (2005).
9. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
10. Conze, D.B., Wu, C.J., Thomas, J.A., Landstrom, A. & Ashwell, J.D. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28, 3538-3547 (2008).
11. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
12. Yamazaki, K. et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci. Signal. 2, ra66 (2009).
13. Hiscott, J. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18, 483-490 (2007).
14. Hoshino, K. et al. Critical role of IκB kinase α in TLR7/9-induced type I IFN production by conventional dendritic cells. J. Immunol. 184, 3341-3345 (2010).
15. Balkhi, M.Y., Fitzgerald, K.A. & Pitha, P.M. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell. Biol. 28, 7296-7308 (2008).
16. Reis, L.F., Ruffner, H., Stark, G., Aguet, M. & Weissmann, C. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J. 13, 4798-4806 (1994).
17. Yarilina, A., Park-Min, K.H., Antoniv, T., Hu, X. & Ivashkiv, L.B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378-387 (2008).
18. Liu, J., Guan, X., Tamura, T., Ozato, K. & Ma, X. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279, 55609-55617 (2004).
19. Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and Toll-like receptor signaling. Immunity 39, 454-469 (2013).
20. Venkatesh, D. et al. Endothelial TNF receptor 2 Induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment. Immunity 38, 1025-1037 (2013).
21. Brien, J.D. et al. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8+ T cell immune responses against West Nile virus infection. PLoS Pathog. 7, e1002230 (2011).
22. Tada, Y., Ho, A., Matsuyama, T. & Mak, T.W. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-J. Exp. Med. 185, 231-238 (1997).
23. Ning, S., Campos, A.D., Darnay, B.G., Bentz, G.L. & Pagano, J.S. TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein. Mol. Cell. Biol. 28, 6536-6546 (2008).
24. Negishi, H. et al. Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. USA 103, 15136-15141 (2006).
25. Shultz, D.B., Rani, M.R., Fuller, J.D., Ransohoff, R.M. & Stark, G.R. Roles of IKK-β, IRF1, and p65 in the activation of chemokine genes by interferon-γ. J. Interferon Cytokine Res. 29, 817-824 (2009).
26. Lin, R., Heylbroeck, C., Genin, P., Pitha, P.M. & Hiscott, J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19, 959-966 (1999).
27. Kawai, T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894 (2001).
28. Dinarello, C.A. Anti-inflammatory agents: present and future. Cell 140, 935-950 (2010).
29. Leon, L.R., Conn, C.A., Glaccum, M. & Kluger, M.J. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am. J. Physiol. 271, R1668-R1675 (1996).
30. Penninger, J.M. et al. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 7, 243-254 (1997).
31. Fitzgerald, K.A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (2003).
32. Zeng, W., Xu, M., Liu, S., Sun, L. & Chen, Z.J. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF. Mol. Cell 36, 315-325 (2009).
33. Schoemaker, M.H. et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J. Hepatol. 36, 742-750 (2002).
34. Alvarez, S.E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF. Nature 465, 1084-1088 (2010).
35. Pitson, S.M. et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500 (2003).
36. Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G. & Wu, H. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. Mol. Cell 38, 101-113 (2010).
37. Paugh, S.W. et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 112, 1382-1391 (2008).
38. Zarnegar, B.J. et al. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378 (2008).
39. Petersen, S.L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445-456 (2007).
40. Csomos, R.A., Brady, G.F. & Duckett, C.S. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF. J. Biol. Chem. 284, 20531-20539 (2009).
41. Hinz, M. et al. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol. Cell 40, 63-74 (2010).
42. Narayan, V., Pion, E., Landre, V., Muller, P. & Ball, K.L. Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP. J. Biol. Chem. 286, 607-619 (2011).
43. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D.V. TRAF6 is a signal transducer for interleukin. Nature 383, 443-446 (1996).
44. Yester, J.W., Tizazu, E., Harikumar, K.B. & Kordula, T. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer Metastasis Rev. 30, 577-597 (2011).
45. Morris, G.M. et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639-1662 (1998).
46. Daffis, S., Suthar, M.S., Szretter, K.J., Gale, M. Jr. & Diamond, M.S. Induction of IFN-β and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF. PLoS Pathog. 5, e1000607 (2009).
47. Kordula, T. et al. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273, 4112-4118 (1998).
48. Hait, N.C. et al. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J. Biol. Chem. 280, 29462-29469 (2005).
49. Hait, N.C. et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257 (2009).
50. Wallace, A.C., Laskowski, R.A. & Thornton, J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134 (1995).